Objective: To collect and analyze the reported literature of Melastoma dodecandrum

summarize the paper distribution

chemical compositions

pharmacological activity

quality control

clinical application and patent application status

and provide reference and literature for its clinical application and further development. Method: With “CNKI” and “Pubmed” as the search platform

“key words” and “abstract” as search terms

“diren”

“gagoulu”

“Melastoma dodecandrum Lour.” and “M. dodecandrum” as search words

the papers and patents of M. dodecandrum at home and abroad from 1973 to 2017 were retrieved in this study. Result: 119 papers and 139 patents were obtained

mainly about agriculture and forestry cultivation

chemical composition

quality control and pharmacological activity research in papers

and mainly about compound products in patents. At present

83 chemical constituents were isolated and identified from M. dodecandrum

mainly including flavonoids. Quality control indicators mainly included gallic acid

quercetin and so on

and the pharmacological research was mainly on hypoglycemic effect. Conclusion: M. dodecandrum had significant hemostatic effects with rich resource and high market competitiveness. However

the local standards were not complete

lacking specific indicators to evaluate the quality of medicinal herbs. Therefore

it is necessary to explore the mechanism of hemostasis in depth

study the basis of its active substances

and establish the relationship between spectrum efficiency and efficacy so as to control the quality of medicinal herbs

and promote the utilization and development of natural medicine resources.